It introduced inhibitory effect of alpha Klein New City through the inhibition of mesenchymal cme go lectin -1 derived from stem cells in Parkinson's disease

The present invention relates to α- Sinus method to treat Parkinson's diseases which are associated with the coagulation of Klein, specifically mesenchymal stem cell by using a lectin -1 go derived from the cell surface of the N- methyl -D- aspartate (NMDA ) diseases the treatment or to climb trim parameters for by adjusting the receptor extracellular α- synuclein yen disturb the soil Toshio system, including Parkinson & apos; s neuropathy caused by aggregation of α- synuclein by inhibiting α- synuclein aggregate formation It can be prevented.